Clinical Evidence: How Wegovy vs Mounjaro Dosing Affects Results
Understanding Wegovy vs Mounjaro Dosing Mechanisms
The fundamental difference in Wegovy vs Mounjaro dosing stems from their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro utilises tirzepatide as a dual GIP and GLP-1 receptor agonist. This mechanistic difference influences how each treatment's dosing schedule is structured and how patients may respond to the escalation protocol.
Wegovy's dosing follows a precise 16-week escalation: starting at 0.25mg for weeks 1-4, progressing through 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), before reaching the 2.4mg maintenance dose. This graduated approach helps minimise gastrointestinal side effects whilst allowing your body to adapt to the medication's appetite-suppressing effects. The dose escalation cannot be skipped, as each stage serves a specific purpose in building tolerance.
Wegovy vs Mounjaro Dosing: UK Weight Loss Results Evidence
When evaluating Wegovy vs Mounjaro dosing outcomes, clinical trial evidence provides the most reliable comparison. The STEP trials demonstrate that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, with STEP 3 showing ~16% when combined with intensive behavioural therapy (Wilding et al., NEJM, 2021). The STEP 5 trial confirmed sustainability, with ~clinically studied weight loss maintained at 2 years.
It's important to note that direct head-to-head comparisons between Wegovy vs Mounjaro dosing results cannot be made from separate trials due to different study designs, patient populations, and endpoints. Both treatments have demonstrated efficacy in their respective clinical programmes, and individual response can vary significantly based on adherence to the prescribed dosing schedule and lifestyle modifications.
Wegovy vs Mounjaro Dosing: Pricing and Value in the UK
Understanding the cost implications of Wegovy vs Mounjaro dosing helps inform treatment decisions. At EverydayMeds, Wegovy pricing reflects the structured dose escalation: 0.25mg starter dose costs £79.99, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers benefit from our FIRST40 discount code, whilst returning patients use DOSE25, both applied at checkout to reach these final prices.
Our bundle options provide convenient multi-month supplies: the Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first 12 weeks, whilst the Progress Trio (0.5mg, 1mg, 1.7mg) is £369.99. For maintenance phase patients, the Ultimate Stability Trio provides three months of 2.4mg supply for £649.99. These bundles offer convenience benefits including Reliable Supply continuity and single delivery arrangements.
How Wegovy's Dosing Schedule Supports Weight Management
Wegovy's structured dosing protocol works by progressively activating GLP-1 receptors in your brain's appetite control centres and digestive system. Starting with the 0.25mg dose allows your body to adapt gradually, reducing the likelihood of gastrointestinal side effects that might otherwise interrupt treatment. As you progress through 0.5mg, 1mg, and 1.7mg phases, the medication increasingly promotes feelings of fullness after smaller meals and may help reduce food cravings. The 2.4mg maintenance dose represents the optimal therapeutic level demonstrated in clinical trials, where patients experienced the most significant weight management benefits when combined with lifestyle modifications.
EverydayMeds Wegovy Ordering Process and Dosing Support
Accessing Wegovy through EverydayMeds begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our UK-based prescribers (GPhC #9012878) review your application within 3 working days, or 24 hours with express service, ensuring the prescribed dosing schedule aligns with clinical guidelines. Once approved, your Wegovy pen is dispatched via next-day cold-chain delivery, maintaining the medication's integrity from our temperature-controlled facilities. Each pen arrives with detailed dosing instructions, injection technique guidance, and access to our clinical support team throughout your treatment journey. This process ensures you receive appropriate medical supervision whilst following the correct Wegovy vs Mounjaro dosing considerations for your individual circumstances.
Storage and Practical Considerations: Wegovy vs Mounjaro Dosing
Practical storage differences between Wegovy vs Mounjaro dosing regimens can influence treatment choice, particularly for UK patients who travel frequently. Wegovy offers superior portability, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day limit. Both medications require refrigeration at 2-8°C before first use, but Wegovy's extended room temperature stability provides greater flexibility for business travel, holidays, or irregular schedules. The FlexTouch pen design features a dose counter and easy-grip surface, with each pen containing four weekly doses. This practical advantage, combined with the once-weekly injection schedule, can improve adherence to your prescribed dosing protocol.
UK-Specific Wegovy vs Mounjaro Dosing Considerations and NICE Guidance
In the UK healthcare context, Wegovy vs Mounjaro dosing decisions must consider NICE guidance TA875, which recommends Wegovy for adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities, alongside specialist weight management support. The structured 16-week dose escalation aligns with NHS weight management pathways, allowing healthcare providers to monitor patient response and adjust support accordingly. MHRA licensing covers the established 0.25mg to 2.4mg dosing range, with additional monitoring requirements (Black Triangle ▼) reflecting the medication's relatively recent market introduction.
UK prescribers often prefer Wegovy's established dosing protocol due to extensive STEP trial data and clear escalation guidelines. The predictable 4-week intervals between dose increases allow for systematic monitoring of weight loss progress, side effect management, and treatment adherence. This structured approach supports shared decision-making between patients and prescribers, particularly important given the long-term commitment required for sustained weight management outcomes.
Start Your Wegovy Journey with Expert Dosing Support
Making an informed choice between Wegovy vs Mounjaro dosing requires professional medical guidance tailored to your individual circumstances. At EverydayMeds, our GPhC-registered prescribers provide comprehensive assessment and ongoing support throughout your weight management journey. Complete your clinical assessment today to determine if Wegovy's proven dosing protocol aligns with your goals, with prices starting from £79.99 using discount code FIRST40 for new customers or DOSE25 for returning patients. Both codes are applied at checkout, and approved orders benefit from next-day delivery with full cold-chain protection. Visit https://everydaymeds.co.uk/collections/wegovy to begin your consultation and access the clinical evidence that supports thousands of successful weight management journeys across the UK.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
